IBDEI25Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34556,1,3,0)
 ;;=3^Conversion D/O w/ Mixed Symptoms
 ;;^UTILITY(U,$J,358.3,34556,1,4,0)
 ;;=4^F44.7
 ;;^UTILITY(U,$J,358.3,34556,2)
 ;;=^5003582
 ;;^UTILITY(U,$J,358.3,34557,0)
 ;;=F68.10^^134^1753^7
 ;;^UTILITY(U,$J,358.3,34557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34557,1,3,0)
 ;;=3^Factitious D/O Imposed on Self,Unspec
 ;;^UTILITY(U,$J,358.3,34557,1,4,0)
 ;;=4^F68.10
 ;;^UTILITY(U,$J,358.3,34557,2)
 ;;=^5003663
 ;;^UTILITY(U,$J,358.3,34558,0)
 ;;=F54.^^134^1753^10
 ;;^UTILITY(U,$J,358.3,34558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34558,1,3,0)
 ;;=3^Psychological Factors Affecting Other Med Conditions
 ;;^UTILITY(U,$J,358.3,34558,1,4,0)
 ;;=4^F54.
 ;;^UTILITY(U,$J,358.3,34558,2)
 ;;=^5003627
 ;;^UTILITY(U,$J,358.3,34559,0)
 ;;=F45.21^^134^1753^8
 ;;^UTILITY(U,$J,358.3,34559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34559,1,3,0)
 ;;=3^Illness Anxiety D/O
 ;;^UTILITY(U,$J,358.3,34559,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,34559,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,34560,0)
 ;;=F68.A^^134^1753^6
 ;;^UTILITY(U,$J,358.3,34560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34560,1,3,0)
 ;;=3^Factitious D/O Imposed on Another
 ;;^UTILITY(U,$J,358.3,34560,1,4,0)
 ;;=4^F68.A
 ;;^UTILITY(U,$J,358.3,34560,2)
 ;;=^5157309
 ;;^UTILITY(U,$J,358.3,34561,0)
 ;;=L98.1^^134^1753^5
 ;;^UTILITY(U,$J,358.3,34561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34561,1,3,0)
 ;;=3^Factitial Dermatitis
 ;;^UTILITY(U,$J,358.3,34561,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,34561,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,34562,0)
 ;;=N94.3^^134^1753^9
 ;;^UTILITY(U,$J,358.3,34562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34562,1,3,0)
 ;;=3^Premenstrual Tension Syndrome
 ;;^UTILITY(U,$J,358.3,34562,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,34562,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,34563,0)
 ;;=F91.2^^134^1754^1
 ;;^UTILITY(U,$J,358.3,34563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34563,1,3,0)
 ;;=3^Conduct D/O,Adolescent-Onset Type
 ;;^UTILITY(U,$J,358.3,34563,1,4,0)
 ;;=4^F91.2
 ;;^UTILITY(U,$J,358.3,34563,2)
 ;;=^5003699
 ;;^UTILITY(U,$J,358.3,34564,0)
 ;;=F91.1^^134^1754^2
 ;;^UTILITY(U,$J,358.3,34564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34564,1,3,0)
 ;;=3^Conduct D/O,Childhood-Onset Type
 ;;^UTILITY(U,$J,358.3,34564,1,4,0)
 ;;=4^F91.1
 ;;^UTILITY(U,$J,358.3,34564,2)
 ;;=^5003698
 ;;^UTILITY(U,$J,358.3,34565,0)
 ;;=F91.9^^134^1754^3
 ;;^UTILITY(U,$J,358.3,34565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34565,1,3,0)
 ;;=3^Conduct D/O,Unspec
 ;;^UTILITY(U,$J,358.3,34565,1,4,0)
 ;;=4^F91.9
 ;;^UTILITY(U,$J,358.3,34565,2)
 ;;=^5003701
 ;;^UTILITY(U,$J,358.3,34566,0)
 ;;=F63.81^^134^1754^6
 ;;^UTILITY(U,$J,358.3,34566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34566,1,3,0)
 ;;=3^Intermittent Explosive D/O
 ;;^UTILITY(U,$J,358.3,34566,1,4,0)
 ;;=4^F63.81
 ;;^UTILITY(U,$J,358.3,34566,2)
 ;;=^5003644
 ;;^UTILITY(U,$J,358.3,34567,0)
 ;;=F63.2^^134^1754^7
 ;;^UTILITY(U,$J,358.3,34567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34567,1,3,0)
 ;;=3^Kleptomania
 ;;^UTILITY(U,$J,358.3,34567,1,4,0)
 ;;=4^F63.2
 ;;^UTILITY(U,$J,358.3,34567,2)
 ;;=^5003642
 ;;^UTILITY(U,$J,358.3,34568,0)
 ;;=F91.3^^134^1754^8
 ;;^UTILITY(U,$J,358.3,34568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34568,1,3,0)
 ;;=3^Oppositional Defiant D/O
